Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 2 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 3 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 4 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 5 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 6 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 7 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 8 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 9 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 10 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 11 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 12 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 13 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 14 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 15 | Hematopoietic cell lineage 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 16 | Human immunodeficiency virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 17 | Human immunodeficiency virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 18 | Human immunodeficiency virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 19 | Human immunodeficiency virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 20 | Human immunodeficiency virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 21 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 22 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 23 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 24 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 25 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 26 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 27 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 28 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 29 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 30 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 31 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 32 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 33 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 34 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 35 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 36 | Primary immunodeficiency 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 37 | Primary immunodeficiency 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 38 | Primary immunodeficiency 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 39 | Primary immunodeficiency 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 40 | Primary immunodeficiency 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 41 | T cell receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 42 | T cell receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 43 | T cell receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 44 | T cell receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 45 | T cell receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 46 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 47 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 48 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 49 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 50 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|
| 51 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬
| Antithymocyte immunoglobulin (rabbit) | 013 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
|
| 52 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Blinatumomab Blinatumomab 💬
| Blinatumomab | 011 3件: 11, 46, 49 💬
|
| 53 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Muromonab-CD3 Muromonab-CD3 💬
| Muromonab | 060 3件: 60, 96, 97 💬
|
| 54 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Otelixizumab Otelixizumab 💬
| Otelixizumab | 046 1件: 46 💬
|
| 55 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
CD3D 1件: CD3D 💬
|
Visilizumab Visilizumab 💬
| Visilizumab | 096 2件: 96, 97 💬
|